Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;41(6):1290-1293.
doi: 10.1111/liv.14828. Epub 2021 Mar 3.

Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population

Stefano Ciardullo  1   2 , Gianluca Perseghin  1   2
Affiliations

Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population

Stefano Ciardullo et al. Liver Int. 2021 Jun.

Abstract

Data are limited on the epidemiological implications of the recent change in terminology from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD). We therefore performed a cross-sectional study of adults recruited in the 2017-2018 National Health and Nutrition Examination Survey, a representative sample of the general US population. The prevalence of NAFLD and MAFLD based on controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) obtained through vibration-controlled transient elastography (VCTE) were 37.1% (95% CI 34.0-40.4) and 39.1% (95% CI 36.3-42.1), respectively, with higher rates among Hispanic individuals. Agreement between the two definitions was high (Cohen's κ 0.92). Patients with NAFLD and MAFLD also showed similar risk of advanced liver fibrosis (7.5% and 7.4% respectively). Our results suggest that the recent change in diagnostic criteria did not affect the prevalence of the condition in the general United States population.

Keywords: Fibroscan; MAFLD; NAFLD; population; prevalence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

REFERENCES

    1. Eslam M, Newsome PN, Anstee QM, et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202-209.
    1. Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver International. 2020;40(9):2082-2089.
    1. Wong VW-S, Wong GL-H, Woo J, et al. Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease. Clin Gastroenterol Hepatol. 2020. https://doi.org/10.1016/j.cgh.2020.10.046
    1. Eddowes PJ, Sasso M, Allison M, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717-1730.
    1. National Center for Health Statistics. National Health and Nutrition Examination Survey 2017-2018 Laboratory Data. Internet: https://wwwn.cdc.gov/nchs/nhanes/Search/DataPage.aspx?Component=Laborato... (accessed June 2020).

LinkOut - more resources